Zanolimumab (HuMax-CD4), a fully human monoclonal antibody: Efficacy and safety in patients with relapsed or treatment-refractory non-cutaneous CD4+ T-cell lymphoma

Autor:	d'Amore, Francesco Annibale, Radford, J, Jerkeman, M, Relander, Thomas, Tilly, H, Osterborg, Anders, Morschhauser, F, Gramatzki, M, Dreyling, M, Bang, B, Baadsgaard, O, Hagberg, Hans
Jazyk:	angličtina
Rok vydání:	2007
Zdroj:	d'Amore, F A, Radford, J, Jerkeman, M, Relander, T, Tilly, H, Osterborg, A, Morschhauser, F, Gramatzki, M, Dreyling, M, Bang, B, Baadsgaard, O & Hagberg, H 2007, ' Zanolimumab (HuMax-CD4), a fully human monoclonal antibody: Efficacy and safety in patients with relapsed or treatment-refractory non-cutaneous CD4+ T-cell lymphoma ', Blood, pp. 3409 .
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pure_au_____::76ab3ec311c5166db463ef5615a15637 https://pure.au.dk/portal/da/publications/zanolimumab-humaxcd4-a-fully-humanmonoclonal-antibody-efficacy-and-safety-in-patients-with-relapsed-or-treatmentrefractory-noncutaneous-cd4-tcell-lymphoma(3b71bfc0-07e1-11de-8317-000ea68e967b).html Zobrazit plný text záznamu